250 related articles for article (PubMed ID: 32333219)
1. Comparison of CT-based and MRI-based high-risk clinical target volumes in image guided-brachytherapy for cervical cancer, referencing recommendations from the Japanese Radiation Oncology Study Group (JROSG) and consensus statement guidelines from the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC ESTRO).
Iwai Y; Nemoto MW; Horikoshi T; Kanazawa A; Kurokawa M; Saito M; Harada R; Kobayashi H; Uno T
Jpn J Radiol; 2020 Sep; 38(9):899-905. PubMed ID: 32333219
[TBL] [Abstract][Full Text] [Related]
2. High-risk CTV delineation for cervix brachytherapy: Application of GEC-ESTRO guidelines in Australia and New Zealand.
Vinod SK; Lim K; Bell L; Veera J; Ohanessian L; Juresic E; Borok N; Chan P; Chee R; Do V; Govindarajulu G; Sridharan S; Johnson C; Moses D; Van Dyk S; Holloway L
J Med Imaging Radiat Oncol; 2017 Feb; 61(1):133-140. PubMed ID: 27527506
[TBL] [Abstract][Full Text] [Related]
3. Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Deshpande DD; Shrivastava S
Int J Gynecol Cancer; 2011 Aug; 21(6):1110-6. PubMed ID: 21633296
[TBL] [Abstract][Full Text] [Related]
4. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results of a new workflow for MRI/CT-based image-guided brachytherapy in cervical carcinoma.
Nemoto MW; Iwai Y; Togasaki G; Kurokawa M; Harada R; Kobayashi H; Uno T
Jpn J Radiol; 2017 Dec; 35(12):760-765. PubMed ID: 29039108
[TBL] [Abstract][Full Text] [Related]
6. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
[TBL] [Abstract][Full Text] [Related]
7. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
[TBL] [Abstract][Full Text] [Related]
8. Dose-volume parameters and clinical outcome of CT-guided free-hand high-dose-rate interstitial brachytherapy for cervical cancer.
Wang Y; Ye WJ; Du LH; Li AJ; Ren YF; Cao XP
Chin J Cancer; 2012 Dec; 31(12):598-604. PubMed ID: 22640625
[TBL] [Abstract][Full Text] [Related]
9. Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction.
Nesvacil N; Pötter R; Sturdza A; Hegazy N; Federico M; Kirisits C
Radiother Oncol; 2013 Apr; 107(1):75-81. PubMed ID: 23068712
[TBL] [Abstract][Full Text] [Related]
10. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
[TBL] [Abstract][Full Text] [Related]
11. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?
Schmid MP; Nesvacil N; Pötter R; Kronreif G; Kirisits C
Radiother Oncol; 2016 Sep; 120(3):467-472. PubMed ID: 26921168
[TBL] [Abstract][Full Text] [Related]
12. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
[TBL] [Abstract][Full Text] [Related]
13. Dose escalation in brachytherapy for cervical cancer: impact on (or increased need for) MRI-guided plan optimisation.
Paton AM; Chalmers KE; Coomber H; Cameron AL
Br J Radiol; 2012 Dec; 85(1020):e1249-55. PubMed ID: 23175490
[TBL] [Abstract][Full Text] [Related]
14. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring.
Eskander RN; Scanderbeg D; Saenz CC; Brown M; Yashar C
Int J Gynecol Cancer; 2010 Jan; 20(1):47-53. PubMed ID: 20130502
[TBL] [Abstract][Full Text] [Related]
15. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
16. GEC-ESTRO (ACROP)-ABS-CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina.
Kamrava M; Leung E; Bachand F; Beriwal S; Chargari C; D'Souza D; Erickson B; Fokdal L; Han K; Harkenrider M; Lin L; Mahantshetty U; Nesvacil N; Ravi A; Schmid M; Vigneault E; Westerveld H; Yashar C; Nout R
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):654-663. PubMed ID: 36191741
[TBL] [Abstract][Full Text] [Related]
17. Implications for dosimetric changes when introducing MR-guided brachytherapy for small volume cervix cancer: a comparison of CT and MR-based treatments in a single centre.
Dempsey C; Govindarajulu G; Sridharan S; Capp A; O'Brien P
Australas Phys Eng Sci Med; 2014 Dec; 37(4):705-12. PubMed ID: 25344886
[TBL] [Abstract][Full Text] [Related]
18. [MRI based 3D brachytherapy planning of the cervical cancer - our experiences with the use of the uterovaginal Vienna Ring MR CT applicator].
Vojtíšek R; Mouryc F; Cechová D; Ciprová R; Ferda J; Fínek J
Klin Onkol; 2014; 27(1):45-51. PubMed ID: 24635437
[TBL] [Abstract][Full Text] [Related]
19. High-risk clinical target volume delineation in CT-guided cervical cancer brachytherapy: impact of information from FIGO stage with or without systematic inclusion of 3D documentation of clinical gynecological examination.
Hegazy N; Pötter R; Kirisits C; Berger D; Federico M; Sturdza A; Nesvacil N
Acta Oncol; 2013 Oct; 52(7):1345-52. PubMed ID: 23905674
[TBL] [Abstract][Full Text] [Related]
20. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer.
Haack S; Pedersen EM; Jespersen SN; Kallehauge JF; Lindegaard JC; Tanderup K
Acta Oncol; 2010 Oct; 49(7):978-83. PubMed ID: 20831485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
